Cordlife Group Limited (SGX: P8A)
Health Care · Health Care Providers & Services · SG
S$0.12
+7.08% today · -28.4% 1Y
Cordlife Group Limited (SGX: P8A) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $24.25M and employs 596 people.
Over the last twelve months the share price has lost 28.4%, trading between 0.11 and 0.26.
Tweenvest scores Cordlife Group Limited across four factors: quality 66/100, value 67/100, growth 0/100. Its strongest factor is value.
P8A price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $24.25M
- Revenue (TTM)
- $28.56M
- P/E
- —
- EPS
- -0.04
- Dividend yield
- —
- Beta (5Y)
- 0.67
- 52-week high
- S$0.26
- 52-week low
- S$0.11
- Avg volume (3M)
- —
- Shares outstanding
- 256.31M
- Employees
- 596
- Next earnings
- —
About Cordlife Group Limited
Established in Singapore in 2001, Cordlife Group Limited functions as an investment holding company, delivering cord blood banking solutions across a global footprint that includes Singapore, Hong Kong, India, Malaysia, and the Philippines. Its operations are structured into two distinct divisions: Banking and Diagnostics. The Banking division is responsible for the collection, processing, storage, and analysis of vital biological samples such as cord blood, cord lining, and various tissue samples. Meanwhile, the Diagnostics division furnishes an array of diagnostic tests, encompassing genetic and metabolic screenings for newborns, pediatric vision and hearing assessments, allergen testing for children, and genetic evaluations for talent identification. Beyond these core services, Cordlife also engages in corneal lenticule banking, gut microbiome storage, and offers lifestyle-focused genetic screening for adults. The company further provides "Moms Up," a mobile application designed to supply parenting information and resources pertinent to health, wellness, and lifestyle needs. Completing its diverse portfolio, Cordlife offers medical laboratory services, marketing support, property investment, alongside specialized consulting and research and development in the medical and pharmaceutical sectors.
- ISIN
- SG2E64980112
- Founded
- 2001
- Listed since
- Mar 30, 2012
- Exchange
- Singapore Exchange
- Currency
- SGD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Japan Hospice Holdings Inc.TSE: 7061 | $24.80M | ¥463.00 | -2.53% |
| PT Royal Prima TbkIDX: PRIM | $24.73M | Rp131.00 | +6.50% |
| Lotus Eye Hospital and Institute LimitedNSEI: LOTUSEYE | $24.48M | Rs113.93 | -1.51% |
| Pharmaceutical Centre S.A.CSE: VITAF | $24.33M | €— | — |
| Elite Health Systems Inc.OTCPK: EHSI | $24.24M | $0.85 | +21.41% |
| Clarity Medical Group Holding LimitedSEHK: 1406 | $24.21M | HK$— | — |
| Hannah Joseph Hospital LimitedBSE: 544687 | $23.89M | Rs101.85 | +0.05% |
| Bioscience Animal Health Public Company LimitedSET: BIS | $23.77M | ฿2.54 | -0.78% |
Figures last refreshed Oct 11, 2026.